跳至主要内容
临床试验/JPRN-UMIN000000567
JPRN-UMIN000000567已完成未知

Randomized, placebo-controlled, single blind, crossover clinical study to evaluate the relationship between subjective sedation after a single dose of ebastine and gene polymorphisms in pharmacodynamics and pharmacokinetics of ebastine. The healthy Japanese volunteers had experience with subjective sedation after taking the second generation histamine H1 receptor antagonists. - Clinical study on sedative effect of histamine H1 receptor antagonist ebastine. -Study on gene polymorphisms associated with individual difference in subjective symptoms.

Showa University School of Pharmaceutical Sciences Department of Clinical Pharmacy0 个研究点目标入组 20 人开始时间: 2007年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 45years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Inappropriate clinical history for medication study (i.e. drug abuse, alcoholism, diseases of heart, liver, kidney, lung, and blood etc.) or who are ambulatory patients suffering theses diseases. 2. Subjects who are ingested medicine with sedatives or antihistaminic agents during this study. 3. Smoker 4. Any history for drug allergy. 5. Severe alcoholism. 6. Subjects who are inadequate for enrollment judged by the investigator.

研究者

发起方
Showa University School of Pharmaceutical Sciences Department of Clinical Pharmacy

相似试验